Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/533543 stock hub

BOM/533543 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BOM/533543is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.5B
Bombay Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BOM/533543
In the news

Latest news · BOM/533543

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E6.8
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC5.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BOM/533543 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
152
Groups with data
10
Currency
INR
Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
India
Country code
IN
Employees
323
Employees Change
30%
Employees Change Percent
10.24
Enterprise value
INR 1.5B
Exchange
Bombay Stock Exchange
Financial currency
INR
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
INR 1.5B
Price
INR 50.9
Price currency
INR
Rev Per Employee
2,750,637.77x
Sic
2834
Symbol
bom/533543
Website
https://www.brookslabs.net

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
14.69%
EV Earnings
7.12x
EV/EBIT
7.07x
EV/EBITDA
6.63x
EV/Sales
1.73x
P/B ratio
1.27x
P/E ratio
6.81x
P/S ratio
1.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

16
MetricValue
EBIT Margin
7.54%
EBITDA Margin
8.78%
Gross margin
38.14%
Gross Profit
INR 338.8M
Gross Profit Growth
32.22%
Gross Profit Growth Q
-43.46%
Gross Profit Growth3 Y
26.76%
Gross Profit Growth5 Y
2.37%
Net Income
INR 216M
Pretax Margin
24.51%
Profit Margin
24.31%
Profit Per Employee
INR 668,808
Roa5y
-4.04
Roe5y
-22
ROIC
5.43
Roic5y
-8.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr10y
-2%
Cagr1y
-60.03%
Cagr3y
-5.35%
Cagr5y
-8.15%
Revenue Growth
15.44x
Revenue Growth Q
-56.91x
Revenue Growth3 Y
4.01x
Revenue Growth5 Y
1.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

12
MetricValue
Cash
INR 10.5M
Debt
INR 78.3M
Debt EBITDA
INR 0.96
Debt Equity
INR 0.07
Equity
INR 1.2B
Interest Coverage
8.08
Net Cash
INR -67.8M
Net Cash By Market Cap
INR -4.61
Net Debt EBITDA
INR 0.87
Net Debt Equity
INR 0.06
Tangible Book Value
INR 1.2B
Tangible Book Value Per Share
INR 39.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-11.78%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
-18.29%
1Y total return
-60.01%
200-day SMA
100.3
3Y total return
-15.21%
50-day SMA
60.94
50-day SMA vs 200-day SMA
50under200
5Y total return
-34.63%
All Time High
202.8
All Time High Change
-73.58%
All Time High Date
2025-01-07
All Time Low
12.5
All Time Low Change
328.56%
All Time Low Date
2011-12-30
ATR
4.31
Ch YTD
-33.25
High
54
High52
166
High52 Date
2025-08-14
High52ch
-69.33%
Low
50.9
Low52
36.9
Low52 Date
2026-03-30
Low52ch
37.94%
Ma50ch
-12.1%
Price vs 200-day SMA
-46.57%
RSI
35.64
RSI Monthly
38.58
RSI Weekly
35.45
Sharpe ratio
-1.25x
Sortino ratio
-1.86
Total Return
-11.78%
Tr YTD
-33.25
Tr1m
-26.54%
Tr1w
-3.63%
Tr3m
-12.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
INR 67M
Operating Income Growth
142.9
Operating Income Growth Q
-68.39
Operating margin
7.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
13,296,366%
Shares Insiders
54.86%
Shares Institutions
11.06%
Shares Qo Q
-0.1%
Shares Yo Y
11.78%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

45
MetricValue
Average Volume
10,908.2x
Bv Per Share
39.3
Ch10y
-32.53
Ch1m
-26.54
Ch1w
-3.63
Ch1y
-60.01
Ch3m
-12.32
Ch3y
-16.03
Ch5y
-35.26
Ch6m
-49.77
Change
-4.98%
Change From Open
-4.63
Close
53.57
Days Gap
-0.37
Depreciation Amortization
11,012,500
Dollar Volume
932,997
Earnings Date
2026-05-18
EBIT
INR 67M
EBITDA
INR 78M
EPS
INR 7.4
F Score
2
Fiscal Year End
March
Founded
2,002
Graham Number
86.36028
Graham Upside
61.21
Income Tax
INR 1.8M
Is Primary Listing
0
Last Earnings Date
2026-02-06
Last Report Date
2025-12-31
Ma150
83.42
Ma150ch
-35.78%
Ma20
63.29
Ma20ch
-15.35%
Next Earnings Date
2026-05-18
Open
53.37
Position In Range
0
Price Date
2026-05-08
Price EBITDA
INR 18.85
Ptbv Ratio
1.27
Relative Volume
1.68x
Revenue
888,456,000x
Tax By Revenue
0.2x
Tax Rate
0.81%
Tr6m
-49.77%
Volume
18,330
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BOM/533543 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/533543 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-60.0%
S&P 500 1Y: n/a
3Y total return
-15.2%
S&P 500 3Y: n/a
5Y total return
-34.6%
S&P 500 5Y: n/a
10Y total return
-18.3%
S&P 500 10Y: n/a
Ownership

Who owns BOM/533543?

Insider, institutional, and short-interest positioning.

Institutional ownership
+11.1%
Share of float held by funds and institutions
Insider ownership
+54.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+11.8%
Negative means the company is buying back shares.
Technical

BOM/533543 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
35.6
Neutral momentum band
Price vs 200-day MA
-46.6%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-1.25
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BOM/533543

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/533543 stock rating?

bom/533543 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/533543 analysis?

The full report lives at /stocks/bom/533543/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/533543?

The latest report frames bom/533543 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/533543 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.